Ipratropium bromide and Cardiac failure congestive - from FDA reports


Summary

Cardiac failure congestive is found among people who take Ipratropium bromide, especially for people who are female, 60+ old , have been taking the drug for 6 - 12 months, also take medication Furosemide, and have Pain. This review analyzes which people have Cardiac failure congestive with Ipratropium bromide. It is created by eHealthMe based on reports of 9,186 people who have side effects when taking Ipratropium bromide from FDA , and is updated regularly.

What to expect?

If you take Ipratropium bromide and have Cardiac failure congestive, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Ipratropium bromide and have Cardiac failure congestive

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Sep, 23, 2017

9,186 people reported to have side effects when taking Ipratropium bromide.
Among them, 233 people (2.54%) have Cardiac failure congestive


Number of reports submitted per year:

Could Ipratropium bromide cause Cardiac failure congestive?

Time on Ipratropium bromide when people have Cardiac failure congestive *:

  • < 1 month: 33.33 %
  • 1 - 6 months: 16.67 %
  • 6 - 12 months: 50.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Cardiac failure congestive when taking Ipratropium bromide *:

  • female: 55.56 %
  • male: 44.44 %

Age of people who have Cardiac failure congestive when taking Ipratropium bromide *:

  • 0-1: 0.0 %
  • 2-9: 0.56 %
  • 10-19: 0.0 %
  • 20-29: 0.56 %
  • 30-39: 2.78 %
  • 40-49: 8.33 %
  • 50-59: 12.78 %
  • 60+: 75.0 %

Top conditions involved for these people *:

  • Pain (17 people, 7.30%)
  • Rheumatoid Arthritis (13 people, 5.58%)
  • Muscle Spasms (12 people, 5.15%)
  • Osteoporosis (11 people, 4.72%)
  • Primary Pulmonary Hypertension (10 people, 4.29%)

Top co-used drugs for these people *:

  • Furosemide (96 people, 41.20%)
  • Albuterol (82 people, 35.19%)
  • Prednisone (57 people, 24.46%)
  • Lasix (54 people, 23.18%)
  • Digoxin (54 people, 23.18%)

Top other side effects for these people *:

  • Pneumonia (75 people, 32.19%)
  • Atrial Fibrillation/flutter (55 people, 23.61%)
  • Oedema Peripheral (50 people, 21.46%)
  • Anaemia (47 people, 20.17%)
  • Weakness (41 people, 17.60%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Do you have Cardiac failure congestive when taking Ipratropium bromide?

Expand the study to include all drugs with the same ingredients

Cardiac failure congestive and drugs with ingredients of ipratropium bromide.

Expand the study to include reports from both FDA and eHealthMe

Cardiac failure congestive and Ipratropium bromide from FDA and eHealthMe reports

Ipratropium bromide

Ipratropium bromide has active ingredients of ipratropium bromide. It is often used in chronic obstructive pulmonary disease. (latest outcomes from Ipratropium bromide 9,327 users)

Cardiac failure congestive

Cardiac failure congestive has been reported by people with diabetes, type 2 diabetes, high blood pressure, primary pulmonary hypertension (latest reports from 94,382 Cardiac failure congestive patients).

Browse all side effects of Ipratropium bromide

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Cardiac failure congestive

Cardiac failure congestive

Could your condition cause Cardiac failure congestive

Cardiac failure congestive

Related studies

What would happen?

Forecast new side effects and undetected conditions when you take Ipratropium bromide and have Cardiac failure congestive.

User reviews to the study

More reviews >